Literature DB >> 24785217

Genotype-guided dosing of vitamin K antagonists.

Roxana Daneshjou, Teri E Klein, Russ B Altman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24785217      PMCID： PMC4145721          DOI： 10.1056/NEJMc1402521

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Racial differences in the response to drugs--pointers to genetic differences.

Authors:  A J Wood
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

2.  Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans.

Authors:  W Hernandez; E R Gamazon; K Aquino-Michaels; S Patel; T J O'Brien; A F Harralson; R A Kittles; A Barbour; M Tuck; S D McIntosh; J N Douglas; D Nicolae; L H Cavallari; M A Perera
Journal:  Pharmacogenomics J       Date:  2013-09-10       Impact factor: 3.550

3.  Integrating common and rare genetic variation in diverse human populations.

Authors:  David M Altshuler; Richard A Gibbs; Leena Peltonen; David M Altshuler; Richard A Gibbs; Leena Peltonen; Emmanouil Dermitzakis; Stephen F Schaffner; Fuli Yu; Leena Peltonen; Emmanouil Dermitzakis; Penelope E Bonnen; David M Altshuler; Richard A Gibbs; Paul I W de Bakker; Panos Deloukas; Stacey B Gabriel; Rhian Gwilliam; Sarah Hunt; Michael Inouye; Xiaoming Jia; Aarno Palotie; Melissa Parkin; Pamela Whittaker; Fuli Yu; Kyle Chang; Alicia Hawes; Lora R Lewis; Yanru Ren; David Wheeler; Richard A Gibbs; Donna Marie Muzny; Chris Barnes; Katayoon Darvishi; Matthew Hurles; Joshua M Korn; Kati Kristiansson; Charles Lee; Steven A McCarrol; James Nemesh; Emmanouil Dermitzakis; Alon Keinan; Stephen B Montgomery; Samuela Pollack; Alkes L Price; Nicole Soranzo; Penelope E Bonnen; Richard A Gibbs; Claudia Gonzaga-Jauregui; Alon Keinan; Alkes L Price; Fuli Yu; Verneri Anttila; Wendy Brodeur; Mark J Daly; Stephen Leslie; Gil McVean; Loukas Moutsianas; Huy Nguyen; Stephen F Schaffner; Qingrun Zhang; Mohammed J R Ghori; Ralph McGinnis; William McLaren; Samuela Pollack; Alkes L Price; Stephen F Schaffner; Fumihiko Takeuchi; Sharon R Grossman; Ilya Shlyakhter; Elizabeth B Hostetter; Pardis C Sabeti; Clement A Adebamowo; Morris W Foster; Deborah R Gordon; Julio Licinio; Maria Cristina Manca; Patricia A Marshall; Ichiro Matsuda; Duncan Ngare; Vivian Ota Wang; Deepa Reddy; Charles N Rotimi; Charmaine D Royal; Richard R Sharp; Changqing Zeng; Lisa D Brooks; Jean E McEwen
Journal:  Nature       Date:  2010-09-02       Impact factor: 49.962

4.  Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.

Authors:  Minoli A Perera; Larisa H Cavallari; Nita A Limdi; Eric R Gamazon; Anuar Konkashbaev; Roxana Daneshjou; Anna Pluzhnikov; Dana C Crawford; Jelai Wang; Nianjun Liu; Nicholas Tatonetti; Stephane Bourgeois; Harumi Takahashi; Yukiko Bradford; Benjamin M Burkley; Robert J Desnick; Jonathan L Halperin; Sherief I Khalifa; Taimour Y Langaee; Steven A Lubitz; Edith A Nutescu; Matthew Oetjens; Mohamed H Shahin; Shitalben R Patel; Hersh Sagreiya; Matthew Tector; Karen E Weck; Mark J Rieder; Stuart A Scott; Alan H B Wu; James K Burmester; Mia Wadelius; Panos Deloukas; Michael J Wagner; Taisei Mushiroda; Michiaki Kubo; Dan M Roden; Nancy J Cox; Russ B Altman; Teri E Klein; Yusuke Nakamura; Julie A Johnson
Journal:  Lancet       Date:  2013-06-05       Impact factor: 79.321
  4 in total
  6 in total

1.  Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms.

Authors:  K Kubo; M Ohara; M Tachikawa; L H Cavallari; M T M Lee; M S Wen; M G Scordo; E A Nutescu; M A Perera; A Miyajima; N Kaneko; V Pengo; R Padrini; Y T Chen; H Takahashi
Journal:  Pharmacogenomics J       Date:  2016-08-09       Impact factor: 3.550

2.  Genes affecting warfarin response-interactive or additive?

Authors:  Larisa H Cavallari; Julio D Duarte
Journal:  J Clin Pharmacol       Date:  2014-12-30       Impact factor: 3.126

3.  Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.

Authors:  Katarzyna Drozda; Shan Wong; Shitalben R Patel; Adam P Bress; Edith A Nutescu; Rick A Kittles; Larisa H Cavallari
Journal:  Pharmacogenet Genomics       Date:  2015-02       Impact factor: 2.089

4.  Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.

Authors:  Roxana Daneshjou; Eric R Gamazon; Ben Burkley; Larisa H Cavallari; Julie A Johnson; Teri E Klein; Nita Limdi; Sara Hillenmeyer; Bethany Percha; Konrad J Karczewski; Taimour Langaee; Shitalben R Patel; Carlos D Bustamante; Russ B Altman; Minoli A Perera
Journal:  Blood       Date:  2014-07-30       Impact factor: 22.113

5.  VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients.

Authors:  Silvia Misasi; Giuliana Martini; Oriana Paoletti; Stefano Calza; Giovanni Scovoli; Alessandra Marengoni; Sophie Testa; Luigi Caimi; Eleonora Marchina
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

6.  Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study.

Authors:  Karla Claudio-Campos; Aurora Labastida; Alga Ramos; Andrea Gaedigk; Jessicca Renta-Torres; Dariana Padilla; Giselle Rivera-Miranda; Stuart A Scott; Gualberto Ruaño; Carmen L Cadilla; Jorge Duconge-Soler
Journal:  Front Pharmacol       Date:  2017-06-07       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.